In vivo cytokine responses to interleukin-2 immunotherapy after autologous stem cell transplantation in children with solid tumors
- 1 July 2000
- journal article
- clinical trial
- Published by Springer Nature in Bone Marrow Transplantation
- Vol. 26 (1) , 91-96
- https://doi.org/10.1038/sj.bmt.1702431
Abstract
Bone Marrow Transplantation is a high quality, peer-reviewed journal covering all aspects of clinical and basic haemopoietic stem cell transplantation.Keywords
This publication has 21 references indexed in Scilit:
- Daily Low-Dose Subcutaneous Recombinant Interleukin-2 by Alternate Weekly AdministrationAmerican Journal of Clinical Oncology, 1998
- High interleukin-10 serum levels are associated with fatal outcome in patients after bone marrow transplantationBone Marrow Transplantation, 1997
- Differential Role for IL‐2 and IL‐15 in the Inhibition of Apoptosis in Short Term Activated Human LymphocytesScandinavian Journal of Immunology, 1997
- Clinical and immunomodulatory effects of repetitive 2-day cycles of high-dose continuous infusion IL-2European Journal Of Cancer, 1997
- Induction of circulating interleukin 10 by interleukin 1 and interleukin 2, but not interleukin 6 immunotherapyCytokine, 1995
- Myeloablative radiochemotherapy and hematopoietic stem-cell rescue in poor-prognosis Ewing's sarcoma.Journal of Clinical Oncology, 1993
- Temporal sequence and cellular origin of interleukin-2 stimulated cytokine gene expressionBritish Journal of Cancer, 1993
- Interleukin‐2: Use in solid tumorsThe International Journal of Cell Cloning, 1993
- Interleukin 2 infusion induces haemopoietic growth factors and modifies marrow regeneration after chemotherapy or autologous marrow transplantationBritish Journal of Haematology, 1991
- Induction of circulating tumor necrosis factor (TNFα) as the mechanism for the febrile response to interleukin-2 (IL-2) in cancer patientsJournal of Clinical Immunology, 1988